Partial Thromboplastin Time (PTT) Test: Normal Range, Interpretation & Clinical Use

Reference Range

  • Typical: 25–35 seconds (varies by lab/reagent/instrument).
  • Always use the performing lab's reference interval.

What PTT Measures

Time for clot formation via the **intrinsic + common pathway** after adding phospholipid (partial thromboplastin) and contact activator (kaolin, silica, ellagic acid) to citrated plasma.

Factors Assessed

  • Factors XII, XI, IX, VIII, X, V, II (prothrombin), Fibrinogen.
  • Prekallikrein, high-molecular-weight kininogen (contact factors).
  • Inhibitors: Heparin, lupus anticoagulant, specific factor inhibitors.

Clinical Indications

  • Monitor **unfractionated heparin** (target 1.5–2.5 × control).
  • Screen for **hemophilia A/B** (VIII, IX deficiency).
  • Evaluate **von Willebrand disease** (vWF carries VIII).
  • Pre-op bleeding risk assessment.
  • DIC, liver disease, lupus anticoagulant workup.

Interpretation of Abnormal Results

Next Steps for Prolonged PTT

  1. Mixing study (1:1 patient plasma : normal plasma) → corrects? = factor deficiency; doesn't correct = inhibitor.
  2. Specific factor assays.
  3. Heparin assay / anti-Xa if on heparin.
  4. Lupus anticoagulant panel (dRVVT, hexagonal phospholipid).

PTT is a screening test. Diagnosis requires integration with clinical picture and specific assays.

Chronic Fatigue Syndrome - Related Articles

Health Sciences © https://www.222health.com

PatternSuggests
Prolonged PTT, normal PTIntrinsic pathway factor deficiency (VIII, IX, XI, XII), heparin, lupus anticoagulant
Prolonged PTT + PTCommon pathway (X, V, II, fibrinogen), liver disease, DIC, warfarin
Shortened PTTAcute phase (elevated VIII/fibrinogen), early DIC, technical error